New Research Reinforces the Link Between Working and Cancer Recovery
Led by MSK oncologist, Dr. Victoria Blinder, new research is examining a question that many cancer survivors confront during treatment and beyond: does continuing to work—or returning to work— support better health outcomes?
New Breast Cancer Advances - Impact to Employer Costs and Outcomes
Two novel therapies have demonstrated significant survival improvements for patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer—one of the most common breast cancer subtypes, representing ~70% of cases.
MSK Direct helps benefits managers guide employees and members through diagnosis, treatment, and return to work with practical resources and expert support.
Discover how MSK Direct partner ADP drives stronger engagement and better outcomes for their employees.
MSK Direct can help you drive greater awareness and utilization of the program through targeted, ongoing communications to your employees and members. See how our close partnership with ADP increased program engagement and reinforced the company’s commitment to supporting those affected by cancer.
Watch Dr. Robert Sidlow, an MSK Internist, for an engaging webinar that dives into the critical role of cancer screening, recognizing key signs and symptoms, preventative and proactive health behaviors, and essential cancer screening guidelines.
Watch Memorial Sloan Kettering Cancer Center nutritionist, Cara Anselmo, and oncologist, Dr. Robert Daly, as they tackle misinformation and provide science-backed insights to help you make informed choices.
